PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
Serial Number: 85654186 |
Filing Date: 06/18/2012 |
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
85654186 |
MARK INFORMATION |
*MARK |
INSITE |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
INSITE |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font, style, size, or color. |
REGISTER |
Principal |
APPLICANT INFORMATION |
*OWNER OF MARK |
Clinical Financial Services, LLC |
DBA/AKA/TA/Formerly |
DBA CFS Clinical |
INTERNAL ADDRESS |
1st Floor |
*STREET |
1000 Madison Avenue |
*CITY |
Audubon |
*STATE
(Required for U.S. applicants) |
Pennsylvania |
*COUNTRY |
United States |
*ZIP/POSTAL CODE
(Required for U.S. applicants only) |
19403 |
WEBSITE ADDRESS |
www.clinicalfinancialservices.com |
LEGAL ENTITY INFORMATION |
TYPE |
limited liability company |
STATE/COUNTRY WHERE LEGALLY ORGANIZED |
Pennsylvania |
GOODS AND/OR SERVICES AND BASIS INFORMATION |
INTERNATIONAL CLASS |
035 |
*IDENTIFICATION |
Clinical trial management services, namely, development of investigator grant budgets, negotiation and administration of investigator grants,
and negotiation and administration of clinical trial agreements; business management services in the field of clinical trials, namely, compilation and management of information required for
regulatory submissions |
FILING BASIS |
SECTION 1(b) |
INTERNATIONAL CLASS |
036 |
*IDENTIFICATION |
Financial services, namely administering payments in compliance with contracts in connection with the conducting of clinical trials; financial
consulting services relating to facilitation and management of clinical trials |
FILING BASIS |
SECTION 1(b) |
INTERNATIONAL CLASS |
042 |
*IDENTIFICATION |
Software as a Service (SAAS) services featuring software for managing the administrative and financial aspects of clinical trials |
FILING BASIS |
SECTION 1(b) |
ATTORNEY INFORMATION |
NAME |
Gregory S. Bernabeo |
ATTORNEY DOCKET NUMBER |
018537.96592 |
FIRM NAME |
Saul Ewing LLP |
INTERNAL ADDRESS |
38th Floor |
STREET |
1500 Market Street |
CITY |
Philadelphia |
STATE |
Pennsylvania |
COUNTRY |
United States |
ZIP/POSTAL CODE |
19102 |
PHONE |
215-972-7755 |
FAX |
215-972-4156 |
EMAIL ADDRESS |
trademarks@saul.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
OTHER APPOINTED ATTORNEY |
Mark D. Simpson, Stephen J. Driscoll |
CORRESPONDENCE INFORMATION |
NAME |
Gregory S. Bernabeo |
FIRM NAME |
Saul Ewing LLP |
INTERNAL ADDRESS |
38th Floor |
STREET |
1500 Market Street |
CITY |
Philadelphia |
STATE |
Pennsylvania |
COUNTRY |
United States |
ZIP/POSTAL CODE |
19102 |
PHONE |
215-972-7755 |
FAX |
215-972-4156 |
EMAIL ADDRESS |
trademarks@saul.com;gbernabeo@saul.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
FEE INFORMATION |
NUMBER OF CLASSES |
3 |
FEE PER CLASS |
325 |
*TOTAL FEE DUE |
975 |
*TOTAL FEE PAID |
975 |
SIGNATURE INFORMATION |
SIGNATURE |
/G.J Seminack/ |
SIGNATORY'S NAME |
Gregory Seminack |
SIGNATORY'S POSITION |
President |
DATE SIGNED |
06/18/2012 |
PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
Serial Number: 85654186 |
Filing Date: 06/18/2012 |
To the Commissioner for Trademarks:
MARK: INSITE (Standard Characters, see
mark)
The literal element of the mark consists of INSITE.
The mark consists of standard characters, without claim to any particular font, style, size, or color.
The applicant, Clinical Financial Services, LLC, DBA CFS Clinical, a limited liability company legally organized under the laws of Pennsylvania, having an address of
1st Floor,
1000 Madison Avenue
Audubon, Pennsylvania 19403
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 035: Clinical trial management services, namely, development of investigator grant budgets, negotiation and administration of
investigator grants, and negotiation and administration of clinical trial agreements; business management services in the field of clinical trials, namely, compilation and management of information
required for regulatory submissions
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or
services. (15 U.S.C. Section 1051(b)).
International Class 036: Financial services, namely administering payments in compliance with contracts in connection with the conducting of clinical
trials; financial consulting services relating to facilitation and management of clinical trials
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or
services. (15 U.S.C. Section 1051(b)).
International Class 042: Software as a Service (SAAS) services featuring software for managing the administrative and financial aspects of clinical
trials
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or
services. (15 U.S.C. Section 1051(b)).
For informational purposes only, applicant's website address is: www.clinicalfinancialservices.com
The applicant's current Attorney Information:
Gregory S. Bernabeo and Mark D. Simpson, Stephen J. Driscoll of Saul Ewing LLP
38th Floor
1500 Market Street
Philadelphia, Pennsylvania 19102
United States
The attorney docket/reference number is 018537.96592.
The applicant's current Correspondence Information: |
Gregory S. Bernabeo |
Saul Ewing LLP |
38th Floor
1500 Market Street |
Philadelphia, Pennsylvania 19102 |
215-972-7755(phone) |
215-972-4156(fax) |
trademarks@saul.com;gbernabeo@saul.com (authorized) |
A fee payment in the amount of $975 has been submitted with the application, representing payment for 3 class(es).
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the
applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes
applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either
in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake,
or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
Declaration Signature
Signature: /G.J Seminack/ Date: 06/18/2012
Signatory's Name: Gregory Seminack
Signatory's Position: President
RAM Sale Number: 10880
RAM Accounting Date: 06/18/2012
Serial Number: 85654186
Internet Transmission Date: Mon Jun 18 12:05:45 EDT 2012
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2012061812054506
8807-85654186-4905a42a069fcaf94c14cd6cdb
a96c88-DA-10880-20120618110931322861